2020
DOI: 10.3727/096504020x15791676105394
|View full text |Cite
|
Sign up to set email alerts
|

Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation

Abstract: We aimed to investigate the potential mechanisms of progression and identify novel prognosis-related biomarkers for papillary renal cell carcinoma (PRCC) patients. The related data were derived from The Cancer Genome Atlas (TCGA) and then analyzed by weighted gene coexpression network analysis (WGCNA). The correlation between each module and the clinical traits were analyzed by Pearson’s correlation analysis. Pathway analysis was conducted to reveal potential mechanisms. Hub genes within each module were scre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 43 publications
0
10
0
Order By: Relevance
“…In recent reports, the high expression of PCDH12was found to be associated with the high pathological grade of papillary renal cell carcinoma [32]. As a new type of tumor suppressor gene, SLIT3 has been reported to play a role in breast, liver, lung, and colon cancer, and the promoter methylation of SLIT3 has been reported to be associated with tumor occurrence and progression [33,34].…”
Section: Discussionmentioning
confidence: 99%
“…In recent reports, the high expression of PCDH12was found to be associated with the high pathological grade of papillary renal cell carcinoma [32]. As a new type of tumor suppressor gene, SLIT3 has been reported to play a role in breast, liver, lung, and colon cancer, and the promoter methylation of SLIT3 has been reported to be associated with tumor occurrence and progression [33,34].…”
Section: Discussionmentioning
confidence: 99%
“…GPR4 appeared up-regulated in cholangiocarcinoma, down-regulated in cervical and lung cancers, and increased or decreased in kidney tumors depending on the kind of cancer [150]. Analysis centered in particular cancers revealed the up-regulated expression of GPR4 in head and neck squamous cell carcinoma [151], in renal cell carcinoma [152], in colorectal cancer [153] and in hepatocellular carcinoma [154] and, in most of these studies, its high expression correlated with late stage tumors and poor overall survival [152][153][154][155].…”
Section: Gpr4mentioning
confidence: 94%
“…11 WGCNA is used by studying the relationship between tissue microarray data and clinical features to identify possible biomarkers for predicting relevant cancers and comparing differentially expressed genes and studying the interactions between genes in different modules. 12 In our study, the RNA sequencing (RNA-seq) profile data of MIBC was downloaded from the Cancer Genome Atlas (TCGA) database.…”
Section: Introductionmentioning
confidence: 99%
“…Weighted gene co‐expression network analysis (WGCNA) 7 is a systems biology tool for characterizing gene expression patterns in samples and has been widely used in the analysis of various cancers, 8 such as colorectal cancer, 9 non‐small‐cell lung cancer (NSCLC), 10 and breast cancer 11 . WGCNA is used by studying the relationship between tissue microarray data and clinical features to identify possible biomarkers for predicting relevant cancers and comparing differentially expressed genes and studying the interactions between genes in different modules 12 …”
Section: Introductionmentioning
confidence: 99%